Acinetobacter pragensis

General Information

Acinetobacter pragensis is a fascinating microorganism that has garnered attention due to its remarkable adaptability and resilience in various environments. This species is part of the Acinetobacter genus, which is known for its clinical significance and environmental versatility. One of the most intriguing aspects of A. pragensis is its ability to survive in diverse habitats, ranging from soil and water to hospital settings, making it a subject of interest for both environmental microbiologists and clinical researchers. Genomic Insights: The genome of A. pragensis reveals a wealth of information about its metabolic capabilities and potential for bioremediation. It possesses genes that enable it to degrade a variety of organic compounds, suggesting its potential use in cleaning up environmental pollutants. Additionally, the presence of multiple antibiotic resistance genes highlights its role in studying the mechanisms of resistance and developing strategies to combat multidrug-resistant infections. Biotechnological Potential: A. pragensis has shown promise in biotechnological applications, particularly in the field of bioremediation. Its ability to metabolize and detoxify harmful substances makes it a valuable candidate for environmental cleanup projects. Furthermore, its robust nature allows it to thrive in harsh conditions, which is advantageous for industrial processes that require resilient microbial strains. Clinical Relevance: While not as notorious as some of its Acinetobacter relatives, A. pragensis still poses a potential threat in healthcare settings due to its antibiotic resistance. Understanding its resistance mechanisms can provide insights into the evolution of resistance in Acinetobacter species and aid in the development of new therapeutic approaches. In summary, Acinetobacter pragensis is a microorganism of significant interest due to its environmental versatility, bioremediation potential, and clinical implications. Its study not only enhances our understanding of microbial ecology and evolution but also offers practical applications in medicine and environmental science.

Acinetobacter pragensis is a notable member of the Acinetobacter genus, which is known for its environmental versatility and ability to thrive in various habitats, including soil and water. This species has garnered attention due to its emerging role in human infections, particularly in immunocompromised individuals. Its intrinsic resistance to multiple antibiotics makes it a significant concern in clinical settings, as it can complicate treatment options and lead to prolonged hospital stays. One of the most interesting aspects of A. pragensis is its genetic adaptability, which allows it to acquire resistance genes from other bacteria through horizontal gene transfer. This characteristic not only contributes to its survival in hostile environments but also poses challenges for public health, as it can lead to outbreaks of multidrug-resistant infections. Furthermore, A. pragensis has been studied for its potential in bioremediation processes, particularly in degrading pollutants in contaminated environments. Its metabolic capabilities enable it to utilize a variety of organic compounds, making it a candidate for environmental cleanup efforts. In summary, Acinetobacter pragensis stands out due to its clinical significance, antibiotic resistance, and potential applications in environmental biotechnology, making it a valuable subject for ongoing research in both medical and environmental microbiology.

Taxonomy

Superkingdom: Bacteria

Phylum: Pseudomonadota

Class: Gammaproteobacteria

Order: Moraxellales

Family: Moraxellaceae

Genus: Acinetobacter

Species: Acinetobacter pragensis

NCBI ID

1806892

Genome Info

FTP Path:
ftp.ncbi.nlm.nih.gov/genomes/all/GCF/001/605/895/GCF_001605895.1_ASM160589v1

File for sequence-based predictions:
GCF_001605895.1_ASM160589v1_genomic.fasta

Descriptions

Clinical Implications and Relevance

Source: gpt-4o-mini-2024-07-18

The organism Acinetobacter pragensis is a member of the Acinetobacter genus, which is known for its clinical significance, particularly in hospital settings. This bacterium has been associated with various infections, including ventilator-associated pneumonia, bloodstream infections, and wound infections. Its relevance in human health is underscored by its ability to cause disease, especially in immunocompromised patients or those with underlying health conditions. One of the critical aspects of Acinetobacter pragensis is its pathogenicity. It can form biofilms on medical devices, which contributes to its persistence in clinical environments and complicates treatment options. The organism is also known for its antimicrobial resistance, often exhibiting resistance to multiple classes of antibiotics, including beta-lactams and aminoglycosides. This resistance poses significant challenges in treating infections caused by this pathogen, leading to increased morbidity and mortality rates. In terms of immune evasion, Acinetobacter pragensis employs various strategies, such as altering surface proteins and producing enzymes that degrade host immune factors, allowing it to survive in hostile environments. The organism has been implicated in several outbreaks, particularly in intensive care units, where it can spread rapidly among patients. While Acinetobacter pragensis is primarily recognized for its role as a pathogen, there is ongoing research into its potential applications in biotechnology and medicine. Understanding its mechanisms of resistance and pathogenicity may lead to the development of new therapeutic strategies or the identification of novel targets for antimicrobial agents. However, its clinical implications remain predominantly negative, emphasizing the need for stringent infection control measures in healthcare settings.

Habitat and Ecological Niches

Source: gpt-4o-mini-2024-07-18

Acinetobacter pragensis is a species of bacteria that is primarily associated with urban environments and hospital settings. This microorganism thrives in human-associated habitats, particularly in areas where it can exploit nutrient-rich conditions, such as wounds, skin flora, and medical equipment surfaces. Its adaptability allows it to survive in various ecological niches, including soil and water, although it is most commonly isolated from clinical specimens. In terms of its ecological role, Acinetobacter pragensis is known for its opportunistic pathogenicity, often affecting immunocompromised individuals. It can form biofilms on medical devices, which complicates treatment and increases the risk of infections. This ability to adhere to surfaces and resist antimicrobial agents highlights its importance in hospital-associated infections. Furthermore, Acinetobacter pragensis exhibits notable environmental adaptability, allowing it to withstand harsh conditions, such as desiccation and the presence of disinfectants. This resilience contributes to its persistence in urban biomes and underscores its role in the microbial community dynamics of these environments. Overall, the presence of Acinetobacter pragensis in various biomes emphasizes its significance in both ecological and clinical contexts.

Industrial Application

Source: gpt-4o-mini-2024-07-18

The microorganism Acinetobacter pragensis has shown potential in various industrial applications, particularly in the fields of biotechnology, waste management, and pharmaceutical development. This organism is known for its ability to thrive in diverse environments, making it a candidate for several biotechnological processes. In biotechnology, Acinetobacter pragensis is utilized in biodegradation processes, where it can break down complex organic compounds, including pollutants and waste materials. This capability is particularly valuable in the treatment of industrial effluents, where the organism can help in the detoxification of hazardous substances, thus contributing to environmental sustainability. In the realm of biofuel production, Acinetobacter pragensis has been studied for its potential in fermentation processes that convert biomass into biofuels. The organism's metabolic pathways can be harnessed to produce bioethanol or other biofuels from agricultural waste, providing a renewable energy source while reducing reliance on fossil fuels. Furthermore, Acinetobacter pragensis has applications in pharmaceutical development. Its ability to produce various enzymes can be exploited in the synthesis of pharmaceutical compounds, enhancing the efficiency of drug production processes. The organism's enzymatic activity is particularly relevant in the production of antibiotics and other therapeutic agents, where it can facilitate the conversion of raw materials into active pharmaceutical ingredients. Overall, Acinetobacter pragensis demonstrates significant promise across multiple industries, particularly in waste treatment, biodegradation, and enzyme production, making it a valuable organism for future industrial applications.

Phenotypes and Predictions

The table shows the phenotypes and predictions. Cell colors indicate the class of the value. When literature-based data is available, a checkmark (✓) indicates a correct prediction, while an ✗ indicates an incorrect prediction.

Literature-based phenotypes: 9

LLM predicted phenotypes: 4

Phenotype	High-quality annotation	anthropic/claude-3.5-sonnet	google/gemini-flash-1.5	mistralai/mixtral-8x7b-instruct:nitro	google/gemini-pro-1.5	perplexity/llama-3-sonar-small-32k-chat	openchat/openchat-7b	google/gemini-pro	meta-llama/llama-3-70b-instruct:nitro	anthropic/claude-3-haiku:beta	anthropic/claude-3-haiku:beta	openai/gpt-4	openai/gpt-4	openai/gpt-3.5-turbo-0125	openai/gpt-3.5-turbo-0125	microsoft/wizardlm-2-8x22b	microsoft/wizardlm-2-8x22b	google/palm-2-chat-bison-32k	google/palm-2-chat-bison-32k	openai/gpt-4o	openai/gpt-4o	mistralai/mistral-7b-instruct	mistralai/mistral-7b-instruct	meta-llama/llama-3-8b-instruct:nitro	meta-llama/llama-3-8b-instruct:nitro	microsoft/phi-3-mini-128k-instruct	microsoft/phi-3-mini-128k-instruct	google/gemma-7b-it	google/gemma-7b-it
Motility	FALSE	false ✓	false ✓	false ✓	false ✓	true ✗	false ✓	true ✗	true ✗	true ✗	true ✗	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	true ✗	true ✗	false ✓	false ✓	true ✗	true ✗	true ✗	true ✗	false ✓	false ✓	true ✗	true ✗
Gram staining	gram stain negative	gram stain negative ✓	gram stain negative ✓	gram stain negative ✓	gram stain negative ✓	gram stain negative ✓	gram stain negative ✓	gram stain negative ✓	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓	N/A	gram stain negative ✓
Aerophilicity	aerobic	aerobic ✓	N/A	facultatively anaerobic ✗	aerobic ✓	N/A	N/A	N/A	N/A	N/A	N/A	aerobic ✓	aerobic ✓	facultatively anaerobic ✗	facultatively anaerobic ✗	aerobic ✓	aerobic ✓	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Extreme environment tolerance	FALSE	true ✗	true ✗	false ✓	true ✗	false ✓	false ✓	false ✓	true ✗	true ✗	true ✗	false ✓	false ✓	false ✓	false ✓	true ✗	true ✗	false ✓	false ✓	false ✓	false ✓	true ✗	true ✗	true ✗	true ✗	true ✗	true ✗	true ✗	true ✗
Biofilm formation	N/A	true	true	true	true	true	false	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true	true
Animal pathogenicity	N/A	true	true	false	true	true	false	true	true	true	true	false	false	false	false	true	true	true	true	true	true	false	false	true	true	false	false	true	true
Biosafety level	biosafety level 1	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 1 ✓	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 1 ✓	biosafety level 1 ✓	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗	biosafety level 2 ✗
Health association	N/A	true	true	true	true	true	false	true	true	true	true	true	true	false	false	true	true	true	true	true	true	true	true	true	true	true	true	true	true
Host association	N/A	true	true	true	true	true	false	true	true	true	true	true	true	false	false	true	true	true	true	true	true	true	true	true	true	true	true	false	false
Plant pathogenicity	FALSE	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	true ✗	true ✗
Spore formation	FALSE	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓	false ✓
Hemolysis	gamma	gamma ✓	gamma ✓	N/A	N/A	N/A	N/A	N/A	N/A	alpha ✗	alpha ✗	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cell shape	bacillus	bacillus ✓	coccus ✗	coccus ✗	coccus ✗	coccus ✗	coccus ✗	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	coccus ✗	coccus ✗	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓	bacillus ✓

Back to Search